» Authors » M Minhaj Siddiqui

M Minhaj Siddiqui

Explore the profile of M Minhaj Siddiqui including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 2202
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Razavi S, Khan A, Fu D, Mayer D, McConkey D, Putluri N, et al.
Curr Opin Oncol . 2025 Mar; PMID: 40071441
Purpose Of Review: This review examines the existing literature on metabolic pathways associated with bladder cancer (BC) and investigates four domains: (1) diagnoses, (2) cancer classification (staging & grading), (3)...
2.
Davies-Teye B, Siddiqui M, Zhang X, Johnson A, Burcu M, Onukwugha E, et al.
Cancer Med . 2025 Feb; 14(4):e70644. PMID: 39945337
Purpose: To characterize trends and patterns in treatment characteristics and perioperative outcomes of patients with urothelial muscle-invasive bladder cancer (MIBC). Materials And Methods: We utilized the National Cancer Database to...
3.
4.
Kami Reddy K, Piyarathna D, Park J, Putluri V, Amara C, Kamal A, et al.
JCI Insight . 2024 Sep; 9(17). PMID: 39253977
Bladder cancer (BLCA) mortality is higher in African American (AA) patients compared with European American (EA) patients, but the molecular mechanism underlying race-specific differences are unknown. To address this gap,...
5.
Babalola O, Gebben D, Tarver M, Joyce Lee T, Wang S, Siddiqui M, et al.
Clin Genitourin Cancer . 2024 Jun; 22(4):102113. PMID: 38845330
Introduction: Food and Drug Administration must make decisions about emerging high intensity focused ultrasound (HIFU) devices that may lack relevant clinical oncologic data but present with known side effects. This...
6.
Rana Z, Kamran S, Shetty A, Sutera P, Song Y, Bazyar S, et al.
Eur Urol Oncol . 2024 Apr; 7(5):986-989. PMID: 38641541
Chemoradiation therapy (CRT) is a treatment for muscle-invasive bladder cancer (MIBC). Using a novel transcriptomic profiling panel, we validated prognostic immune biomarkers to CRT using 70 pretreatment tumor samples from...
7.
Khan A, Moore C, Siddiqui M
Eur J Radiol . 2023 Dec; 170:111255. PMID: 38101197
The development of different imaging modalities of the prostate has significantly improved tumor detection, patient risk stratification, and quality of care.Among these, multiparametric magnetic resonance imaging (mp-MRI) has emerged as...
8.
Lyall V, Ould Ismail A, Haggstrom D, Issa M, Siddiqui M, Tosoian J, et al.
Urology . 2023 Sep; 181:92-97. PMID: 37660946
Objective: To determine if accurate documentation of bladder cancer risk was associated with a clinician surveillance recommendation that is concordant with AUA guidelines among patients with nonmuscle invasive bladder cancer...
9.
Wang S, Kozarek J, Russell R, Drescher M, Khan A, Kundra V, et al.
Eur Urol Oncol . 2023 Aug; 7(2):189-203. PMID: 37640584
Context: There has been a dramatic increase in the use of prostate magnetic resonance imaging (MRI) in the diagnostic workup. With prostate volume calculated from MRI, prostate-specific antigen density (PSAD)...
10.
Kennedy A, Lee A, Ambinder D, Naslund M, Siddiqui M, Phelan M, et al.
Urol Pract . 2023 May; 8(3):393-401. PMID: 37145656
Introduction: Surgical experience requires skills traditionally taught through real-time operating room education and a variety of supplemental educational strategies. Video-based coaching is a modality that may offer potential advantages of...